{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T01:50:10Z","timestamp":1777513810343,"version":"3.51.4"},"reference-count":46,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Cutan Med Surg"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The Psoriasis Longitudinal Assessment and Registry (PSOLAR) is a global, prospective, longitudinal, disease-based registry. It serves as a post-marketing safety commitment with a focus on patients with moderate to severe plaque psoriasis who are candidates for systemic therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To describe the baseline disease demographics and clinical characteristics of a Canadian subgroup of participants enrolled in PSOLAR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Baseline demographic\/disease characteristics, medical histories, and previous psoriasis treatments for Canadian patients in PSOLAR were summarized using descriptive statistics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 1896 patients analyzed in the Canadian subgroup at 37 clinical sites, accounting for 15.7% of the global PSOLAR population. Baseline disease and clinical characteristics were as expected for a moderate to severe psoriasis population and were generally similar to the global PSOLAR population. Two distinctions were noted in the Canadian subgroup versus those enrolled globally: a higher proportion of patients were overweight\/obese (84.7% vs. 80.4%) and male (61.4% vs. 54.7%). In addition, the Canadian subgroup had numerically higher historical peak disease activity (PGA score 3.35 vs. 3.1) and longer disease duration (22.3 years vs. 17.5 years). Canadian PSOLAR patients reported a variety of comorbidities, including psoriatic arthritis (31.5%), hypertension (34.6%), hyperlipidemia (24.3%), mental illness (24.1%), and inflammatory bowel disease (1.6%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The Canadian subgroup of PSOLAR patients was generally similar to those enrolled globally with respect to baseline disease demographics and clinical characteristics. Multiple comorbidities are noted in the Canadian subgroup, underscoring the need for a holistic approach to the treatment of psoriatic patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/12034754231191509","type":"journal-article","created":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T02:17:46Z","timestamp":1691806666000},"page":"594-600","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Baseline Characteristics of Canadian Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)"],"prefix":"10.1177","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8926-0113","authenticated-orcid":false,"given":"Melinda J.","family":"Gooderham","sequence":"first","affiliation":[{"name":"SKiN Centre for Dermatology and Probity Medical Research, Peterborough, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5927-6587","authenticated-orcid":false,"given":"Robert","family":"Bissonnette","sequence":"additional","affiliation":[{"name":"Innovaderm Research, Montreal, QC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Kalia","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Skin Science, University of British Columbia and Vancouver Coastal Health Research Institute, Vancouver, BC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim A.","family":"Papp","sequence":"additional","affiliation":[{"name":"Probity Medical Research and Alliance Clinical Trials, Waterloo, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyn C.","family":"Guenther","sequence":"additional","affiliation":[{"name":"Guenther Research Inc., London, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne P.","family":"Gulliver","sequence":"additional","affiliation":[{"name":"Memorial University of Newfoundland and New Lab Life Sciences, St. John\u2019s, NL, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Ho","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Skin Science, University of British Columbia and Vancouver Coastal Health Research Institute, Vancouver, BC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9151-1145","authenticated-orcid":false,"given":"Neil H.","family":"Shear","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Sunnybrook Health Sciences Centre, University of Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2624-2724","authenticated-orcid":false,"given":"Ron","family":"Vender","sequence":"additional","affiliation":[{"name":"Dermatrials Research Inc., Hamilton, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Gniadecki","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vimal H.","family":"Prajapati","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, University of Calgary, Calgary, AB, Canada"},{"name":"Section of Community Pediatrics, Department of Pediatrics, University of Calgary, Calgary, AB, Canada"},{"name":"Department of Pediatrics, Section of Pediatric Rheumatology, Calgary, AB, Canada"},{"name":"Dermatology Research Institute, Calgary, AB, Canada"},{"name":"Skin Health & Wellness Centre, Calgary, AB, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Turchin","sequence":"additional","affiliation":[{"name":"Probity Medical Research and Alliance Clinical Trials, Waterloo, ON, Canada"},{"name":"Brunswick Dermatology Centre, Fredericton, NB, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne","family":"Langholff","sequence":"additional","affiliation":[{"name":"Janssen Research & Development, LLC, Spring House, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9557-3642","authenticated-orcid":false,"given":"Kim","family":"Parnell","sequence":"additional","affiliation":[{"name":"Janssen Scientific Affairs, LLC, Horsham, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott D.","family":"Simpson","sequence":"additional","affiliation":[{"name":"Janssen Inc., Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nastaran","family":"Abbarin","sequence":"additional","affiliation":[{"name":"Janssen Inc., Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omair","family":"Lakhani","sequence":"additional","affiliation":[{"name":"Janssen Inc., Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raed","family":"Alhusayen","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Sunnybrook Health Sciences Centre, University of Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"key":"bibr1-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03730.x"},{"key":"bibr2-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-017-2278-0"},{"key":"bibr3-12034754231191509","volume-title":"Fitzpatrick\u2019s Dermatology in General Medicine","author":"Gudjonsson J.","year":"2012","edition":"8"},{"key":"bibr4-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-017-3895-y"},{"key":"bibr5-12034754231191509","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2009.00024"},{"key":"bibr6-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1016\/j.sder.2010.01.002"},{"key":"bibr7-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1038\/nutd.2012.26"},{"key":"bibr8-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.5015"},{"key":"bibr9-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.07.064"},{"key":"bibr10-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00518-8"},{"key":"bibr11-12034754231191509","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2010.09066"},{"key":"bibr12-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.339"},{"key":"bibr13-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13013"},{"issue":"10","key":"bibr14-12034754231191509","first-page":"1210","volume":"11","author":"Papp KA.","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"bibr15-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.08.032"},{"key":"bibr16-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1186\/s41927-018-0034-7"},{"issue":"10","key":"bibr17-12034754231191509","first-page":"1002","volume":"16","author":"Bissonnette R.","year":"2017","journal-title":"J Drugs Dermatol"},{"key":"bibr18-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.12.017"},{"issue":"7","key":"bibr19-12034754231191509","first-page":"706","volume":"14","author":"Papp K.","year":"2015","journal-title":"J Drugs Dermatol"},{"key":"bibr20-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1177\/1203475417746337"},{"key":"bibr21-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1177\/1203475418773736"},{"key":"bibr22-12034754231191509","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2013.13052"},{"key":"bibr23-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker365"},{"key":"bibr24-12034754231191509","unstructured":"Statistics Canada.\n                      The Daily \u2014 The Canadian Census: A Rich Portrait of the Country\u2019s Religious and Ethnocultural Diversity\n                      . Government of Canada; 2022. Accessed February 6, 2023. https:\/\/www150.statcan.gc.ca\/n1\/daily-quotidien\/221026\/dq221026b-eng.htm"},{"key":"bibr25-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.11.058"},{"issue":"2","key":"bibr26-12034754231191509","first-page":"ii14","volume":"64","author":"Gladman DD.","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"bibr27-12034754231191509","doi-asserted-by":"publisher","DOI":"10.4081\/reumatismo.2012.66"},{"key":"bibr28-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201706"},{"key":"bibr29-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz152"},{"issue":"2","key":"bibr30-12034754231191509","first-page":"121","volume":"86","author":"Correia B.","year":"2015","journal-title":"Acta Biomed"},{"key":"bibr31-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12381"},{"key":"bibr32-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000062"},{"key":"bibr33-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32835bcce1"},{"key":"bibr34-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2009.94"},{"key":"bibr35-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01346-6"},{"key":"bibr36-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.21443"},{"key":"bibr37-12034754231191509","doi-asserted-by":"publisher","DOI":"10.24869\/psyd.2017.401"},{"key":"bibr38-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.508"},{"key":"bibr39-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13908"},{"key":"bibr40-12034754231191509","volume-title":"The Life and Economic Impact of Major Mental Illnesses in Canada: 2011 to 2041","author":"Smetanin P.","year":"2011"},{"key":"bibr41-12034754231191509","unstructured":"Anxiety, feelings of depression and loneliness among Canadians spikes to highest levels since spring 2020. CAMH. Accessed February 8, 2023. https:\/\/camh.ca\/en\/camh-news-and-stories\/anxiety-depression-loneliness-among-canadians-spikes-to-highest-levels"},{"issue":"8","key":"bibr42-12034754231191509","first-page":"891","volume":"146","author":"Kurd SK.","year":"2010","journal-title":"Arch Dermatol"},{"key":"bibr43-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.10.012"},{"key":"bibr44-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.06.883"},{"key":"bibr45-12034754231191509","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12208"},{"key":"bibr46-12034754231191509","unstructured":"Janssen Scientific Affairs, LLC.\n                      A Multicenter, Open Registry of Patients With Plaque Psoriasis Who Are Candidates for Systemic Therapy Including Biologics\n                      . clinicaltrials.gov; 2022. Accessed September 25, 2022. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00508547"}],"container-title":["Journal of Cutaneous Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/12034754231191509","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/12034754231191509","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/12034754231191509","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:50:04Z","timestamp":1777391404000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.sagepub.com\/doi\/10.1177\/12034754231191509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.1177\/12034754231191509"],"URL":"https:\/\/doi.org\/10.1177\/12034754231191509","relation":{},"ISSN":["1203-4754","1615-7109"],"issn-type":[{"value":"1203-4754","type":"print"},{"value":"1615-7109","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,11]]}}}